Effect of Resistance to Third-generation Cephalosporins on Morbidity and Mortality from Bloodstream Infections in Blantyre, Malawi: a Prospective Cohort Study

Overview

Journal Lancet Microbe

Specialties Microbiology
Parasitology

Date 2022 Nov 6

PMID 36335953

Authors

Rebecca Lester

Patrick Musicha

Kondwani Kawaza

Josephine Langton

James Mango

Helen Mangochi

Winnie Bakali

Oliver Pearse

Jane Mallewa

Brigitte Denis

Sithembile Bilima

Stephen B Gordon

David G Lalloo

Christopher P Jewell

Nicholas A Feasey

Affiliations

Soon will be listed here.

Abstract

Background: The burden of antimicrobial resistance is a major threat to global health; however, prospective clinical outcome data from Africa are scarce. In Malawi, third-generation cephalosporins are the antibiotics of choice in patients admitted to hospital despite a rapid proliferation of resistance to these drugs. We aimed to quantify the effect of resistance to third-generation cephalosporins on mortality and length of hospital stay among patients with bloodstream infections.

Methods: We did a prospective cohort study of patients admitted to Queen Elizabeth Central Hospital in Blantyre, Malawi. Patients of all ages who had positive blood cultures for Enterobacterales were included, with the exception of those from the genus Salmonella, and were followed up for 180 days. We characterised blood culture isolates using whole-genome sequencing and used Cox regression models to estimate the effect of resistance to third-generation cephalosporins on length of hospital stay, in-hospital mortality, and survival.

Findings: Between Jan 31, 2018, and Jan 13, 2020, we recruited 326 patients, from whom 220 (68%) of 326 isolates were resistant to third-generation cephalosporins. The case fatality proportion was 45% (99 of 220) in patients with bloodstream infections that were resistant to third-generation cephalosporins, and 34% (36 of 106) in patients with bloodstream infections that were sensitive to third-generation cephalosporins. Resistance to third-generation cephalosporins was associated with an increased probability of in-hospital mortality (hazard ratio [HR] 1·44, 95% CI 1·02-2·04), longer hospital stays (1·5 days, 1·0-2·0) and decreased probability of discharge alive (HR 0·31, 0·22-0·45). Whole-genome sequencing showed a high diversity of sequence types of both Escherichia coli and Klebsiella pneumoniae. Although isolates associated with death were distributed across clades, we identified three E coli clades (ST410, ST617, and ST648) that were isolated from 14 patients who all died.

Interpretation: Resistance to third-generation cephalosporins is associated with increased mortality and longer hospital stays in patients with bloodstream infections in Malawi. These data show the urgent need for allocation of resources towards antimicrobial resistance mitigation strategies in Africa.

Funding: Wellcome Trust and Wellcome Asia and Africa Programme.

Citing Articles

Progress on implementing the WHO-GLASS recommendations on priority pathogen-antibiotic sensitivity testing in Africa: A .

Hope M, Kiggundu R, Tabajjwa D, Tumwine C, Lwigale F, Mwanja H Wellcome Open Res. 2025; 9:692.

PMID: 39931110 PMC: 11809157. DOI: 10.12688/wellcomeopenres.23133.1.

Antibiotic Dispensing Practices Among Community Retail Pharmacies and Registered Drugstores: Results from a Simulated Client Study in Lilongwe, Malawi.

Lubanga A, Bwanali A, Kamanga W, Kathewera B, Makole T, Mpinganjira S Integr Pharm Res Pract. 2024; 13:229-242.

PMID: 39628834 PMC: 11611745. DOI: 10.2147/IPRP.S487530.

Molecular mechanisms of re-emerging chloramphenicol susceptibility in extended-spectrum beta-lactamase-producing Enterobacterales.

Graf F, Goodman R, Gallichan S, Forrest S, Picton-Barlow E, Fraser A Nat Commun. 2024; 15(1):9019.

PMID: 39424629 PMC: 11489765. DOI: 10.1038/s41467-024-53391-2.

Key environmental exposure pathways to antimicrobial resistant bacteria in southern Malawi: A SaniPath approach.

Mwapasa T, Chidziwisano K, Mphasa M, Cocker D, Rimella L, Amos S Sci Total Environ. 2024; 945:174142.

PMID: 38906299 PMC: 11234251. DOI: 10.1016/j.scitotenv.2024.174142.

Aligning antimicrobial resistance surveillance with schistosomiasis research: an interlinked One Health approach.

OFerrall A, Musaya J, Stothard J, Roberts A Trans R Soc Trop Med Hyg. 2024; 118(8):498-504.

PMID: 38842743 PMC: 11299544. DOI: 10.1093/trstmh/trae035.

References

Musicha P, Feasey N, Cain A, Kallonen T, Chaguza C, Peno C . Genomic landscape of extended-spectrum β-lactamase resistance in Escherichia coli from an urban African setting. J Antimicrob Chemother. 2017; 72(6):1602-1609. PMC: 5437524. DOI: 10.1093/jac/dkx058. View

Mahazu S, Prah I, Ayibieke A, Sato W, Hayashi T, Suzuki T . Possible Dissemination of co Sequence Type 410 Closely Related to B4/H24RxC in Ghana. Front Microbiol. 2021; 12:770130. PMC: 8672054. DOI: 10.3389/fmicb.2021.770130. View

Lewis J, Mphasa M, Keyala L, Banda R, Smith E, Duggan J . A Longitudinal, Observational Study of Etiology and Long-Term Outcomes of Sepsis in Malawi Revealing the Key Role of Disseminated Tuberculosis. Clin Infect Dis. 2021; 74(10):1840-1849. PMC: 9155594. DOI: 10.1093/cid/ciab710. View

Schulz zur Wiesch P, Engelstadter J, Bonhoeffer S . Compensation of fitness costs and reversibility of antibiotic resistance mutations. Antimicrob Agents Chemother. 2010; 54(5):2085-95. PMC: 2863634. DOI: 10.1128/AAC.01460-09. View

. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022; 399(10325):629-655. PMC: 8841637. DOI: 10.1016/S0140-6736(21)02724-0. View

Evans C, Jones C, Prendergast A . HIV-exposed, uninfected infants: new global challenges in the era of paediatric HIV elimination. Lancet Infect Dis. 2016; 16(6):e92-e107. DOI: 10.1016/S1473-3099(16)00055-4. View

Mahazu S, Sato W, Ayibieke A, Prah I, Hayashi T, Suzuki T . Insights and genetic features of extended-spectrum beta-lactamase producing Escherichia coli isolates from two hospitals in Ghana. Sci Rep. 2022; 12(1):1843. PMC: 8813988. DOI: 10.1038/s41598-022-05869-6. View

Feng Y, Liu L, Lin J, Ma K, Long H, Wei L . Key evolutionary events in the emergence of a globally disseminated, carbapenem resistant clone in the ST410 lineage. Commun Biol. 2019; 2:322. PMC: 6715731. DOI: 10.1038/s42003-019-0569-1. View

Lester R, Haigh K, Wood A, MacPherson E, Maheswaran H, Bogue P . Sustained Reduction in Third-generation Cephalosporin Usage in Adult Inpatients Following Introduction of an Antimicrobial Stewardship Program in a Large, Urban Hospital in Malawi. Clin Infect Dis. 2020; 71(9):e478-e486. PMC: 7713689. DOI: 10.1093/cid/ciaa162. View

10.

Ben-Ami R, Rodriguez-Bano J, Arslan H, Pitout J, Quentin C, Calbo E . A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients. Clin Infect Dis. 2009; 49(5):682-90. DOI: 10.1086/604713. View

11.

Lester R, Maheswaran H, Jewell C, Lalloo D, Feasey N . Estimating the burden of antimicrobial resistance in Malawi: protocol for a prospective observational study of the morbidity, mortality and economic cost of third-generation cephalosporin resistant bloodstream infection. Wellcome Open Res. 2020; 5:29. PMC: 7290274. DOI: 10.12688/wellcomeopenres.15719.2. View

12.

Prin M, Itaye T, Clark S, Fernando R, Namboya F, Pollach G . Critical Care in a Tertiary Hospital in Malawi. World J Surg. 2016; 40(11):2635-2642. DOI: 10.1007/s00268-016-3578-y. View

13.

Friedman N, Temkin E, Carmeli Y . The negative impact of antibiotic resistance. Clin Microbiol Infect. 2015; 22(5):416-22. DOI: 10.1016/j.cmi.2015.12.002. View

14.

de Kraker M, Stewardson A, Harbarth S . Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050?. PLoS Med. 2016; 13(11):e1002184. PMC: 5127510. DOI: 10.1371/journal.pmed.1002184. View

15.

de Kraker M, Davey P, Grundmann H . Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe. PLoS Med. 2011; 8(10):e1001104. PMC: 3191157. DOI: 10.1371/journal.pmed.1001104. View

16.

Denis B, Lafaurie M, Donay J, Fontaine J, Oksenhendler E, Raffoux E . Prevalence, risk factors, and impact on clinical outcome of extended-spectrum beta-lactamase-producing Escherichia coli bacteraemia: a five-year study. Int J Infect Dis. 2015; 39:1-6. DOI: 10.1016/j.ijid.2015.07.010. View

17.

Burke R, Henrion M, Mallewa J, Masamba L, Kalua T, Khundi M . Incidence of HIV-positive admission and inpatient mortality in Malawi (2012-2019). AIDS. 2021; 35(13):2191-2199. PMC: 7611991. DOI: 10.1097/QAD.0000000000003006. View

18.

Turner P, Ashley E, Celhay O, Douangnouvong A, Hamers R, Ling C . ACORN (A Clinically-Oriented Antimicrobial Resistance Surveillance Network): a pilot protocol for case based antimicrobial resistance surveillance. Wellcome Open Res. 2020; 5:13. PMC: 7250055. DOI: 10.12688/wellcomeopenres.15681.2. View

19.

Musicha P, Msefula C, Mather A, Chaguza C, Cain A, Peno C . Genomic analysis of Klebsiella pneumoniae isolates from Malawi reveals acquisition of multiple ESBL determinants across diverse lineages. J Antimicrob Chemother. 2019; 74(5):1223-1232. PMC: 6477993. DOI: 10.1093/jac/dkz032. View

20.

Ngambi W, Ade S, Harries A, Midiani D, Owiti P, Takarinda K . Follow-up and programmatic outcomes of HIV-exposed infants registered in a large HIV centre in Lilongwe, Malawi: 2012-2014. Trop Med Int Health. 2016; 21(8):995-1002. DOI: 10.1111/tmi.12727. View